Literature DB >> 29768278

Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease.

Gloria Brombo1, Francesco Bonetti1, Beatrice Ortolani1, Mario Luca Morieri1, Cristina Bosi1, Angelina Passaro1, Giovanni B Vigna1, Caterina Borgna2, Maria Vittoria Arcidicono3,4, Veronica Tisato4, Giovanni Zuliani5.   

Abstract

BACKGROUND: The protein Klotho is involved in biological processes related to longevity, cardiovascular health, and cognition. Serum Klotho levels have been associated with better cognition in animal models; moreover, lower Klotho concentrations in cerebrospinal fluid from subjects with late-onset Alzheimer's disease (LOAD) have been reported.
OBJECTIVE: Our study aimed to examine the possible relationship between Klotho plasma concentrations and cognitive status in the elderly.
METHODS: We evaluated plasma Klotho levels in a sample of 320 elderly patients admitted to a Memory Clinic. Four groups of subjects were enrolled, including cognitively intact individuals complaining about memory loss (controls) and patients affected by LOAD, mild cognitive impairment, or vascular dementia (VD). The sample was stratified by plasma Klotho tertiles.
RESULTS: Lower levels of plasma Klotho (1st tertile) were associated with older age, higher prevalence of VD, single/multiple lacunar infarcts and leukoaraiosis, coronary heart disease and stroke, and higher levels of creatinine, homocysteine, and high-sensitivity C-reactive protein. On multivariate logistic regression analysis, the risk of VD was 3- and 4-fold in subjects belonging to the 1st tertile (≤514.8 pg/mL, OR 3.54, 95% CI 1.05-11.93) and 2nd tertile (> 514.8, < 659.1 pg/mL, OR 4.28, 95% CI 1.30-14.06) compared to the 3rd tertile (≥659.1 pg/mL). A significantly increased VD risk was found for Klotho values < 680 pg/mL.
CONCLUSION: In a sample of elderly individuals, we found a significant association between low plasma Klotho levels and VD, but not LOAD. This finding suggests that, although these 2 forms of dementia might overlap, some physiopathological mechanisms related to VD and LOAD remain distinct.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Klotho; Late-onset Alzheimer’s disease; Mild cognitive impairment; Vascular dementia

Mesh:

Substances:

Year:  2018        PMID: 29768278     DOI: 10.1159/000488318

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  6 in total

Review 1.  Could α-Klotho Unlock the Key Between Depression and Dementia in the Elderly: from Animal to Human Studies.

Authors:  Xiang Gao; Yuhong Li; Zuoli Sun; Hong Xu; Guangwei Ma; Qi Deng; Claire X Zhang; Rena Li
Journal:  Mol Neurobiol       Date:  2021-02-01       Impact factor: 5.590

2.  Phosphate Dysregulation and Neurocognitive Sequelae.

Authors:  John Acquaviva; Hosam G Abdelhady; Mohammed S Razzaque
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Emerging Biomarkers in Vascular Cognitive Impairment and Dementia: From Pathophysiological Pathways to Clinical Application.

Authors:  Virginia Cipollini; Fernanda Troili; Franco Giubilei
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

4.  Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke.

Authors:  Ho Geol Woo; Yoonkyung Chang; Dong-Ryeol Ryu; Tae-Jin Song
Journal:  PLoS One       Date:  2019-08-09       Impact factor: 3.240

5.  The Association of Obesity and the Antiaging Humoral Factor Klotho in Middle-Aged and Older Adults.

Authors:  Carlos H Orces
Journal:  ScientificWorldJournal       Date:  2022-08-24

Review 6.  "Bridging the Gap" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era.

Authors:  Donato Gemmati; Katia Varani; Barbara Bramanti; Roberta Piva; Gloria Bonaccorsi; Alessandro Trentini; Maria Cristina Manfrinato; Veronica Tisato; Alessandra Carè; Tiziana Bellini
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.